Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228175 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Varenicline: Testing Individual Differences
A Phase 4 study, sponsored by The Mind Research Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 218
- Enrollment target
NCT01228175: Completed Phase 4 study, sponsored by The Mind Research Network.
NCT01228175 is a Phase 4 study that has completed, run by The Mind Research Network. The registered enrollment target is 218 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01228175, a Phase 4 study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 218 participants
- Enrollment target
Study Summary
The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
Primary Outcome
The number of cigarettes smoked were assessed only on a "smoking day", i.e., when a participant smoked at least 1 cigarette. Data was recorded each day for up to 36 weeks.
Interventions
- DRUG Placebo
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
What the finished NCT01228175 record still lists
NCT01228175 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01228175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01228175 about?
NCT01228175 is a clinical study titled "Effectiveness of Varenicline: Testing Individual Differences". The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
What is the current status of trial NCT01228175?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 218 participants. The study started on 2010-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01228175?
The interventions under investigation include: Placebo (DRUG), Varenicline (DRUG).
Who is sponsoring clinical trial NCT01228175?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01228175's enrollment target sits among peer trials
218 390th of 2000 higher than 1,608 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia